Skip to Content

Join the 'Diabetes, Type 2' group to help and get support from people like you.

Diabetes, Type 2 News

Related terms: Noninsulin-dependent Diabetes, Type 2 Diabetes, Diabetes, Type 2

No More Than 6 Teaspoons of Added Sugars a Day for Kids

Posted 5 days ago by

MONDAY, Aug. 22, 2016 – Children and teens should consume less than six teaspoons of added sugars a day, a new American Heart Association statement advises. "Our target recommendation is the same for all children between the ages of 2 and 18, to keep it simple for parents and public health advocates," statement lead author Dr. Miriam Vos said in a heart association news release. Added sugars are any sugars, including table sugar, fructose and honey, used in processing and preparing foods or beverages, added to foods at the table, or eaten separately. "For most children, eating no more than six teaspoons of added sugars per day is a healthy and achievable target," Vos explained. She is a nutrition scientist and associate professor of pediatrics at Emory University School of Medicine in Atlanta. The statement also said children younger than 2 years should not consume foods or beverages ... Read more

Related support groups: Diabetes, Type 2, Obesity, Weight Loss, Prevention of Cardiovascular Disease, Cardiovascular Risk Reduction

Fatty Fish May Curb Eye Risks for Diabetics, Study Finds

Posted 9 days ago by

THURSDAY, Aug. 18, 2016 – Two servings of fish a week may be enough to lower the heightened risk for blindness that those with diabetes face, a new Spanish study suggests. Diabetic retinopathy is a serious complication of type 2 diabetes resulting from a drop-off in blood supply to the patient's retina. According to lead researcher Aleix Sala-Vila, it is the most frequent cause of diabetes-related blindness. "We wanted to [see] whether regular consumption of seafood – fatty fish in particular – in the absence of any advice to increase seafood consumption or fish oil supplementation decreased the risk of diabetic retinopathy," explained Sala-Vila, a researcher at the Centro de Investigacion Biomedica en Red in Barcelona. Sala-Vila's team focused on patients whose overall diet was already composed of mostly low-fat or plant-based foods. That said, the team found that those who consumed ... Read more

Related support groups: Diabetes, Type 2, Diabetes, Type 1, Fish Oil, Lovaza, Insulin Resistance, Vitamin/Mineral Supplementation and Deficiency, Pre-Diabetes, Diabetes Mellitus, Omega-3, Vitamin/Mineral Supplementation during Pregnancy/Lactation, Omacor, Abnormal Glucose Tolerance, Gestational Diabetes, Omega-3 Polyunsaturated Fatty Acids, MaxEPA, Restora, EPA Fish Oil, Animi-3, Omega 3-6-9 Complex, Marine Lipid Concentrate

Health Tip: The Pluses of Using an Insulin Pump

Posted 12 days ago by

-- An insulin pump delivers insulin directly, without messing with syringes and bottles of insulin. The American Diabetes Association mentions these likely benefits: No more single injections of insulin. More accurate dosing and delivery of insulin. More stable blood sugar, including fewer severe lows. Greater flexibility in when and what you eat. No unpredictable reactions to long-acting or intermediate-acting insulin. Read more

Related support groups: Diabetes, Type 2, Insulin, Diabetes, Type 1, Insulin Resistance, Abnormal Glucose Tolerance, Intravenous Insulin Drip

When Diabetes Strikes, Get Moving to Lower Risk to Eyes

Posted 4 Aug 2016 by

THURSDAY, Aug. 4, 2016 – People with diabetes who remain inactive may have higher odds for a vision-robbing eye condition, new research suggests. While the study couldn't prove a cause-and-effect relationship, researchers say a "couch potato" lifestyle does seem to raise the risk for diabetic retinopathy. According to the U.S. National Eye Institute, the condition "involves changes to retinal blood vessels that can cause them to bleed or leak fluid, distorting vision." Diabetic retinopathy is the most common cause of vision loss for people with diabetes. Could exercise – or a lack of it – affect risk for the disease? To find out, a team led by Paul Loprinzi at the University of Mississippi tracked outcomes for 282 U.S. diabetes patients. The patients averaged 62 years of age. Nearly one-third (29 percent) had mild or more severe diabetic retinopathy. Using an accelerometer device to ... Read more

Related support groups: Diabetes, Type 2, Eye Conditions, Insulin Resistance, Pre-Diabetes, Diabetes Mellitus, Retinal Disorders, Diabetic Retinopathy, Abnormal Glucose Tolerance, Retinitis Pigmentosa, Visual Defect/Disturbance, Retinal Vasculitis, Retinal Hemorrhage, Retinopathy Prophylaxis

Health Tip: Warning Signs of Nerve Damage

Posted 3 Aug 2016 by

-- Nerve damage caused by fluctuating blood sugar can be dangerous, particularly for people with diabetes. The condition can affect most any tissues of the body, but notably the heart and circulatory system. The American Diabetes Association says potential warning signs of neuropathy include: Feeling dizzy or fainting after standing up. Fainting for no apparent reason. Rapid heartbeat when you are at rest. Having a heart attack without chest pain or other common warning signs. Read more

Related support groups: Diabetes, Type 2, Heart Attack, Diabetes, Type 1, Diabetic Neuropathy, Insulin Resistance, Diabetic Nerve Damage, Pre-Diabetes, Myocardial Infarction, Diabetes Mellitus, Abnormal Glucose Tolerance, Myocardial Infarction - Prophylaxis

Diabetes Drug Victoza Might Not Help Advanced Heart Failure Patients

Posted 2 Aug 2016 by

TUESDAY, Aug. 2, 2016 – The diabetes drug liraglutide (Victoza) doesn't appear to improve heart function in patients with advanced heart failure, a new study finds. The theory for this trial was that this drug – from a class of medications called (GLP-1) agonists – might interact with the heart's GLP-1 receptors on cells and thereby improve heart function. "We were hoping for a benefit; we didn't see that. It's at best neutral," said lead researcher Dr. Kenneth Margulies. He's a professor of medicine and research director of heart failure and transplantation at the University of Pennsylvania in Philadelphia. Previous studies found evidence that people with advanced heart failure have insulin resistance of their peripheral muscles and heart muscle, and "this was felt to be a detrimental feature that this type of diabetes medicine might help," he said. Not only did the drug not help, ... Read more

Related support groups: Diabetes, Type 2, Victoza, Heart Failure, Congestive Heart Failure, Insulin Resistance, Saxenda, Pre-Diabetes, Liraglutide, Left Ventricular Dysfunction, Diabetes Mellitus, Abnormal Glucose Tolerance, Left Ventriculography

Adlyxin Approved for Type 2 Diabetes

Posted 1 Aug 2016 by

THURSDAY, July 28, 2016 – Adlyxin (lixisenatide) has been approved by the U.S. Food and Drug Administration to treat type 2 diabetes in adults, the agency said Thursday in a news release. As the FDA explained, Adlyxin is a "glucagon-like peptide-1 receptor agonist" – a hormonal drug that helps control blood sugar. The drug was evaluated in clinical studies involving 5,400 people with type 2 diabetes. A separate study was held involving 6,000 type 2 diabetics at risk for atherosclerotic cardiovascular disease, the FDA said. Type 2 diabetes affects more than 29 million people in the United States, accounting for about 90 percent of diagnosed cases of diabetes, the agency said. Elevated blood sugar caused by the disease can lead to complications including heart disease, blindness and nerve and kidney damage. The most common side effects of Adlyxin included nausea, vomiting, headache, ... Read more

Related support groups: Diabetes, Type 2, Adlyxin, Lixisenatide

Treating Psoriasis May Reduce Risk for Other Ills

Posted 29 Jul 2016 by

FRIDAY, July 29, 2016 – Treating the skin disease psoriasis might reduce your risk for other health problems as well, a dermatology expert says. About 7.5 million people in the United States have the chronic skin disease. The inflammatory effects of psoriasis can affect the entire body, said Dr. Jashin Wu, director of dermatology research at Kaiser Permanente Los Angeles Medical Center. "People with psoriasis, particularly those with more severe disease, have an increased risk for a variety of other health problems, including obesity, diabetes, high blood pressure, high cholesterol, stroke and heart attack," he said in an American Academy of Dermatology news release. Psoriasis is characterized by red, raised patches of skin, or plaques, covered with silvery-white scales. It's also marked by itching, burning or soreness of the skin. It is not contagious. "Psoriasis patients, even those ... Read more

Related support groups: High Blood Pressure, Diabetes, Type 2, Obesity, Hypertension, High Cholesterol, Heart Attack, Psoriasis, Inflammatory Conditions, Insulin Resistance, Pre-Diabetes, Myocardial Infarction, Plaque Psoriasis, Diabetes Mellitus, Abnormal Glucose Tolerance, Myocardial Infarction - Prophylaxis, Psoriatic Arthropathy

FDA OKs New Injectable Type 2 Diabetes Medication

Posted 28 Jul 2016 by

THURSDAY, July 28, 2016 – The injectable drug Adlyxin (lixisenatide) has been approved to treat adults with type 2 diabetes, the U.S. Food and Drug Administration says. The once-daily injection is to be used along with diet and exercise to improve patients' blood sugar levels. The FDA reviewed 10 clinical trials on the safety and effectiveness of Adlyxin. These studies included 5,400 people with type 2 diabetes. The drug was also specifically tested for heart issues in an additional 6,000 people at risk of heart disease, the FDA said Thursday in a news release. The FDA concluded that Adlyxin helps normalize blood sugar levels. And it doesn't appear to increase the risk of heart problems. Adlyxin is in a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. Other GLP-1 drugs include liraglutide (Victoza), exenatide (Byetta, Bydureon) and dulaglutide (Trulicity), ... Read more

Related support groups: Diabetes, Type 2, Victoza, Insulin Resistance, Byetta, Bydureon, Saxenda, Pre-Diabetes, Trulicity, Liraglutide, Diabetes Mellitus, Exenatide, Abnormal Glucose Tolerance, Dulaglutide, Adlyxin, Lixisenatide

Sanofi Receives FDA Approval of Adlyxin (lixisenatide) for Treatment of Adults With Type 2 Diabetes

Posted 28 Jul 2016 by

PARIS, July 27, 2016 /PRNewswire/ – Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved Adlyxin (lixisenatide), a once-daily mealtime GLP-1 receptor agonist injection indicated as an adjunct to diet and exercise for the treatment of adults with type 2 diabetes. "The approval of Adlyxin reaffirms our continued commitment to addressing the challenges faced by people living with diabetes when trying to reach and maintain their individual blood glucose (HbA1c) targets," said Peter Guenter, Executive Vice President, Head, Global Diabetes & Cardiovascular Business Unit, Sanofi. "We are pleased with this approval, as it offers us the opportunity to continue helping patients treated with basal insulin who remain uncontrolled." The approval of Adlyxin was based on FDA review of results from the GetGoal clinical program and findings from the ELIXA trial, which ... Read more

Related support groups: Diabetes, Type 2, Adlyxin, Lixisenatide

Health Tip: Ease Arthritis Pain With Warm Water

Posted 27 Jul 2016 by

-- When joints are stiff and sore, warm water can be just what the doctor ordered. Here's how to reap the benefits of warm water, courtesy of the Arthritis Foundation: Make the water between 92 degrees and 100 degrees Fahrenheit. Use a warm tub (or pool) to do some stretching. Place a tennis ball beneath the small of your back in the bathtub and roll it gently along the bottom of the tub. Soak in a bath with Epsom salts. But people with diabetes should avoid too much salt, which could trigger insulin production. Read more

Related support groups: Diabetes, Type 2, Rheumatoid Arthritis, Osteoarthritis, Diabetes, Type 1, Diabetes Mellitus

Flu Shot Tied to Fewer Hospitalizations, Deaths in Type 2 Diabetes Patients

Posted 26 Jul 2016 by

TUESDAY, July 26, 2016 – The seasonal flu vaccine may offer people with type 2 diabetes some protection against dying prematurely, a new study suggests. The flu shot also appeared to protect those with type 2 diabetes from hospitalizations for stroke, as well as heart and breathing problems, the study said. British researchers looked at a large group – more than 124,500 people – with type 2 diabetes. People with type 2 diabetes normally have a higher risk of cardiovascular problems, the researchers noted. During the seven-year study, the researchers found that flu vaccination was associated with a 19 percent reduction in flu-season hospital admissions for heart attack in people with type 2 diabetes. Hospital admissions for stroke were 30 percent lower for those who got a flu vaccination. Admissions were also down 22 percent for heart failure, and 15 percent for pneumonia or influenza ... Read more

Related support groups: Diabetes, Type 2, Influenza, Insulin Resistance, Pre-Diabetes, Diabetes Mellitus, Influenza A, FluLaval, Afluria, Abnormal Glucose Tolerance, FluMist, Fluzone, Influenza Virus Vaccine, Inactivated, Vaccination and Prophlaxis, Influenza Prophylaxis, Flucelvax, Fluarix Quadrivalent, Fluvirin, Influenza Virus Vaccine, Live, Trivalent, Fluad, Flucelvax 2015-2016

FDA Expands Indication For Type 2 Diabetes Treatment Synjardy (Empagliflozin/Metformin Hydrochloride) To Include Treatment-Naïve Adults

Posted 22 Jul 2016 by

RIDGEFIELD, Conn., and INDIANAPOLIS, July 19, 2016 /PRNewswire/ – The U.S. Food and Drug Administration has approved an expanded indication for Synjardy (empagliflozin and metformin hydrochloride) tablets to include treatment-naïve adults with type 2 diabetes (T2D). Synjardy, from Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY), is indicated as an adjunct to diet and exercise to improve glycemic control in adults with T2D when treatment with both empagliflozin and metformin is appropriate. Synjardy is a combination of empagliflozin (Jardiance) and metformin — two medicines with complementary mechanisms of action — to help control blood glucose in adults with T2D. Empagliflozin, a sodium glucose co-transporter-2 inhibitor, removes excess glucose through the urine by blocking glucose re-absorption in the kidney. Metformin, a commonly prescribed initial treatment for T2D, lowe ... Read more

Related support groups: Diabetes, Type 2, Metformin, Synjardy, Empagliflozin/metformin, Empagliflozin

Living Past 90 Doesn't Doom You to Disease, Disability

Posted 21 Jul 2016 by

THURSDAY, July 20, 2016 – What if you could live well into your 90s and still be in good health? A new study suggests that may be possible, particularly if you have good genes. "Chronic disease is not an inevitable part of aging," said Dr. Sofiya Milman, an assistant professor of medicine at the Albert Einstein College of Medicine in New York City. "An extended period of good health can accompany a long life span and is an achievable goal." Milman is one of the authors of a U.S. National Institutes of Health-funded study on aging. Americans are living longer than ever. In 2014, the average life expectancy at birth had reached nearly 79 years, according to the U.S. National Center for Health Statistics. A century earlier, it was just slightly over 54 years. But gains in "health span – the period of time that people live in good health – have not kept pace with longevity, the study ... Read more

Related support groups: Diabetes, Type 2, Cancer, Ischemic Stroke, Osteoporosis, Transient Ischemic Attack, Fracture, bone, Prevention of Osteoporosis, Diabetes Mellitus, Prevention of Cardiovascular Disease, Ischemic Stroke - Prophylaxis, Cardiovascular Risk Reduction, Prevention of Fractures

Brisk Walking May Help Ward Off Diabetes

Posted 20 Jul 2016 by

WEDNESDAY, July 20, 2016 – Brisk walking may be more effective than jogging in controlling blood sugar levels in people with prediabetes, a new study suggests. People with prediabetes have higher-than-normal blood sugar levels but not so high that it's full-blown diabetes. The "gold standard" approach to diabetes prevention involves weight loss, diet and exercise. "We know the benefits of lifestyle changes ... but it is difficult to get patients to do even one behavior, not to mention three," said study author Dr. William Kraus. So he and his colleagues wanted to know if exercise alone could achieve similar benefits. "When faced with the decision of trying to do weight loss, diet and exercise versus exercise alone, the study indicates you can achieve nearly 80 percent of the effect of doing all three with just a high amount of moderate-intensity exercise," said Kraus, a professor of ... Read more

Related support groups: Diabetes, Type 2, Insulin Resistance, Pre-Diabetes, Diabetes Mellitus, Abnormal Glucose Tolerance

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Diabetic Ketoacidosis (in DM Type II), Diabetic Coma (in DM Type II), Diabetes Mellitus

Related Drug Support Groups

metformin, Victoza, Lantus, Januvia, Glucophage, Novolog, glipizide, Humalog, Janumet, view more... Welchol, Byetta, glyburide, Bydureon, Lantus Solostar, Invokana, Actos, Levemir, glimepiride, Trulicity, Novolin R, Amaryl, bromocriptine, Onglyza, chromium picolinate, liraglutide, Novolin N, pioglitazone, Tradjenta, Avandia, Humulin N, Glucophage XR, Humulin R, Prandin, NovoLog FlexPen, GlipiZIDE XL, Glucotrol, Farxiga, Humalog KwikPen, sitagliptin, Symlin, Jardiance, Tanzeum, ActoPlus Met, Toujeo, Glumetza, Glucotrol XL, acarbose, Apidra, insulin glargine, Novolin 70 / 30, glyburide / metformin, Humalog Mix 75 / 25, colesevelam, Jentadueto, Janumet XR, Tresiba, Starlix, Avandamet, nateglinide, gotu kola, Afrezza, Glyxambi, Glucovance, repaglinide, lavender, NovoLog Mix 70 / 30, insulin regular, Novolin R PenFill, Symlin Pen, Humulin N Pen, DiaBeta, linagliptin, exenatide, metformin / pioglitazone, rosiglitazone, Nesina, Oseni, miglitol, saxagliptin, Kombiglyze XR, alogliptin, NPH Insulin, Cycloset, insulin aspart, Precose, Basaglar, Xigduo XR, Fortamet, Riomet, ReliOn / Novolin N, Exubera, Novolin R Innolet, Iletin NPH, Novolin N PenFill, Humalog Mix 50 / 50 Pen, Insulin Pork Mix, Novolin N Innolet, Humulin 70 / 30 Pen, NovoLog PenFill, metformin / sitagliptin, Apidra Solostar, chlorpropamide, glimepiride / pioglitazone, Invokamet, Toujeo Solostar, Synjardy, Adlyxin, Ryzodeg 70 / 30, glipizide / metformin, insulin detemir, Humalog Mix 50 / 50 KwikPen, SymlinPen 60, PrandiMet, tolazamide, Kazano, insulin lispro / insulin lispro protamine, ReliOn / Novolin 70 / 30, Humulin 70 / 30, alogliptin / pioglitazone, canagliflozin, dulaglutide, dapagliflozin, Humulin U, insulin degludec, Glynase, Micronase, insulin isophane, Humalog Mix 75 / 25 KwikPen, insulin inhalation, rapid acting, insulin zinc, insulin glulisine, Juvisync, Tolinase, alogliptin / metformin, steviocalcitriol, albiglutide, insulin lispro, insulin isophane / insulin regular, canagliflozin / metformin, Lente Iletin II, lixisenatide, insulin aspart / insulin degludec, acetohexamide, Glycron, Diabinese, Jentadueto XR, empagliflozin / metformin, empagliflozin / linagliptin, ReliOn / Humulin R, insulin zinc extended, Preflin, insulin aspart / insulin aspart protamine, Glyset, glimepiride / rosiglitazone, dapagliflozin / metformin, empagliflozin, SymlinPen 120, Iletin Lente, Insulin Lente Pork, Novolin L, Iletin II Lente Pork, Metaglip, Tol-Tab, Humulin 50 / 50, pramlintide, Humulin L, tolbutamide, Insulin Purified NPH Pork, Iletin II Regular Pork, Velosulin BR, Iletin II NPH Pork, Chromium GTF, Rezulin, Cr-GTF, Orinase, Novolin 70 / 30 Innolet, Avandaryl, Novolog Mix 70 / 30 PenFill, NovoLog Mix 70 / 30 FlexPen, Duetact, ReliOn / Novolin R, linagliptin / metformin, simvastatin / sitagliptin, metformin / saxagliptin, metformin / rosiglitazone, metformin / repaglinide, Humalog Mix 50 / 50, Glynase PresTab, Novolin 70 / 30 PenFill, Humalog Mix 75 / 25 Pen, troglitazone, Dymelor, Lantus OptiClik Cartridge, Iletin Regular